IP Library Granted Patent US 11,974,910
Granted Patent B2
US 11,974,910 · App. 18/342,553 · Granted May 7, 2024

System for treating embolism and associated devices and methods

Inventors: Ben Merritt (San Clemente, CA); Jacqueline Macias (Fullerton, CA); Brian Michael Strauss (San Clemente, CA); Thomas Tu (Louisville, KY); John Coleman Thress (Capistrano Beach, CA); Paul Lubock (Monarch Beach, CA)
Assignee: Inari Medical, Inc.
A61F2/01A61B17/12109A61M1/815A61M1/84A61B2017/22034A61B2017/22079A61B17/221A61B2217/005A61M1/79A61M25/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,974,910
App. No.
18/342,553
Filed
Jun 27, 2023
Granted
May 7, 2024
Kind
B2
Art Unit
3781
USPC
606/127
Abstract

Systems and methods for the intravascular treatment of clot material within a blood vessel of a human patient are disclosed herein. A method in accordance with embodiments of the present technology can include, for example, positioning a distal portion of a catheter proximate to the clot material within the blood vessel. The method can further include coupling a pressure source to the catheter via a tubing subsystem including a valve or other fluid control device and, while the valve is closed, activating the pressure source to charge a vacuum. The valve can then be opened to apply the vacuum to the catheter to thereby aspirate at least a portion of the clot material from the blood vessel and into the catheter.

Claims (43)

1. A clot treatment system for treating clot material comprising a pulmonary embolism in a vasculature of a patient, comprising:

a first clot aspiration assembly, including:

a first catheter;

a first pressure source; and

a first fluid control device between the first catheter and the first pressure source, wherein the first fluid control device is movable between (a) a first position in which the first pressure source is fluidly disconnected from the first catheter and (b) a second position in which the first pressure source is fluidly connected to the first catheter,

wherein the first pressure source is configured to generate vacuum pressure while the first fluid control device is in the first position, and

wherein, upon movement of the first fluid control device from the first position to the second position, the vacuum pressure is applied to the first catheter to generate suction at a distal portion of the first catheter; and

a second clot aspiration assembly, including:

a second catheter advanceable through the first catheter, wherein the second catheter has a distal portion, wherein the second catheter has a size of 16 French or greater, and wherein the second catheter is shaped to be intravascularly advanced through the vasculature of the patient such that the distal portion of the second catheter is positioned proximate to the pulmonary embolism;

a second pressure source; and

a second fluid control device between the second catheter and the second pressure source, wherein the second fluid control device is movable between (a) a first position in which the second pressure source is fluidly disconnected from the second catheter and (b) a second position in which the second pressure source is fluidly connected to the second catheter,

wherein the second pressure source is configured to generate vacuum pressure while the second fluid control device is in the first position, and

wherein, upon movement of the second fluid control device from the first position to the second position, the vacuum pressure is applied to the second catheter to generate suction at the distal portion of the second catheter to aspirate blood and at least a portion of the pulmonary embolism into the second catheter.

2. The clot system of claim 1 wherein the first catheter has a first length, and wherein the second catheter has a second length longer than the first length.

3. The clot treatment system of claim 1 wherein the first catheter has a size of 24 French, and wherein the size of the the second catheter has is 16 French.

4. The clot treatment system of claim 1 wherein the first pressure source is the same as the second pressure source.

5. The clot treatment system of claim 1 wherein the first pressure source and the second pressure source comprise an electric pump.

6. The clot treatment system of claim 1 wherein the first clot aspiration assembly further includes a hemostasis valve configured to receive the second catheter.

7. The clot treatment system of claim 6 wherein the hemostasis valve comprises:

a tubular member defining a lumen configured to slidably receive the second catheter; and

a filament extending at least partially around the tubular member, wherein the filament is moveable between (a) a first position wherein the filament circumferentially constricts the lumen to create a seal around the second catheter and (b) a second position wherein the filament is moved to at least partially open the lumen.

8. The clot treatment system of claim 1 wherein the first fluid control device is user actuatable to move between the first position and the second positions of the first fluid control device, and wherein the second fluid control device is user actuatable to move between the first positoin and the second position of the second fluid control device.

9. The clot treatment system of claim 1 wherein the first pressure source is a first syringe, and wherein the second pressure source is a second syringe.

10. The clot treatment system of claim 1 wherein the first pressure source is a first vacuum-pressure locking syringe, and wherein the second pressure source is a second vacuum-pressure locking syringe.

11. A clot treatment system for treating clot material comprising a pulmonary embolism in a vasculature of a patient, comprising:

a first clot aspiration assembly, including:

a first catheter; and

a first pressure source configured to be fluidly coupled to the first catheter and to generate suction at a distal portion of the first catheter; and

a second clot aspiration assembly, including:

a second catheter advanceable through the first catheter, wherein the second catheter has a distal portion, wherein the second catheter has a size of 16 French or greater, and wherein the second catheter is shaped to be intravascularly advanced through the vasculature of the patient such that the distal portion of the second catheter is positioned proximate to the pulmonary embolism;

a second pressure source; and

a fluid control device between the second catheter and the second pressure source, wherein the fluid control device is movable between (a) a first position in which the second pressure source is fluidly disconnected from the second catheter and (b) a second position in which the second pressure source is fluidly connected to the second catheter,

wherein the second pressure source is configured to generate vacuum pressure while the fluid control device is in the first position, and

wherein, upon movement of the fluid control device from the first position to the second position, the vacuum pressure is applied to the second catheter to generate suction at the distal portion of the second catheter to aspirate blood and at least a portion of the pulmonary embolism into the second catheter.

12. The clot treatment system of claim 11 wherein the first catheter has a size of 24 French, and wherein the size of the the second catheter is 16 French.

13. The clot treatment system of claim 11 wherein the first pressure source is the same as the second pressure source.

14. The clot treatment system of claim 11 wherein the first pressure source and the second pressure source comprise an electric pump.

15. The clot treatment system of claim 11 wherein the first clot aspiration assembly further includes a hemostasis valve configured to receive the second catheter.

16. The clot treatment system of claim 15 wherein the hemostasis valve is fluidly coupled to a proximal end portion of the first catheter, and wherein the first pressure source is fluidly coupled to the first catheter via a tube branching from the first catheter distal to the proximal end portion of the first catheter.

17. The clot treatment system of claim 16 wherein the hemostasis valve is a first hemostasis valve, wherein the tube is a first tube, and wherein the second clot aspiration assembly further includes a second hemostasis valve fluidly coupled to a proximal end portion of the second catheter, and wherein the second pressure source is fluidly coupled to the second catheter via a second tube branching from the second catheter distal to the proximal end portion of the second catheter.

18. The clot treatment system of claim 11 wherein the first catheter has a size of 24 French, wherein the size of the second catheter is 16 French, and wherein the first pressure source and the second pressure source comprise an electric pump.

19. The clot treatment systme of claim 15 wherein the first pressure source is the same as the second pressure source.

20. The clot treatment systme of claim 7 wherein the first pressure source is the same as the second pressure source.

Assignments (4)
NUNC PRO TUNC ASSIGNMENT Recorded Apr 29, 2026
From: INARI MEDICAL, INC.
To: STRYKER CORPORATION
Reel/Frame 075486/0805 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 9, 2024
From: THRESS, JOHN COLEMAN; LUBOCK, PAUL
To: INARI MEDICAL, INC.
Reel/Frame 068238/0224 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 6, 2023
From: MERRITT, BEN; MACIAS, JACQUELINE; STRAUSS, BRIAN MICHAEL
To: INARI MEDICAL, INC.
Reel/Frame 064812/0040 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 6, 2023
From: TU, THOMAS
To: INARI MEDICAL, INC.
Reel/Frame 064812/0095 →
Continuity (7)
Continuation 18167757 · Feb 10, 2023
Continuation 17976711 · Oct 28, 2022
Continuation 17865315 · Jul 14, 2022
Continuation 16536185 · Aug 8, 2019
Provisional Application 62718248 · Aug 13, 2018
Provisional Application 62718269 · Aug 13, 2018
Related Publication 20230338131A1 · Oct 26, 2023
Cited By (15)
US 12,239,333 US 12,251,120 US 12,274,459 US 12,285,182 US 12,310,608 US 12,343,028 US 12,350,443 US 12,364,496 US 12,453,564 US 12,465,382 US 12,496,081 US 12,558,112 US 12,558,486 US 12,685,549 US 12,702,538